Home
News & Events
Press releases
Events
Company
Strategy
History
Investors
Management & BoD
Pipeline
Pipeline (diagram)
Nefecon (PL-56)
Busulipo™ (MZH-2)
Business Development
In-Licensing
Out- Licensing
Contact
Contact Details
Directions Map
Apr 14, 2015
Pharmalink announces positive result in Phase 2b Trial of Nefecon®
Category: Pressrelease
Pharmalink announces positive result in Phase 2b Trial of Nefecon®
Read Pressrelease [pdf]
Print
Return
News & Events
Apr 14, 2015
Pharmalink announces positive result in Phase 2b Trial of Nefecon®
[pdf]
Mar 18, 2015
Pharmalink acquires novel therapeutic product candidate for treating inflammation associated with osteoarthritis
[pdf]
Jan 21, 2015
Pharmalink announces an open Investigational New Drug (IND) application for Nefecon®
[pdf]
Nov 3, 2014
Data from clinical study of Pharmalink's Nefecon® to be presented at American Society of Nephrology's Kidney Week 2014
[pdf]